This concurs with the observations of Shlush et al. [9] who found (in ten patients with AML) that DNMT3A mutations in AML were present in differentiation competent haemopoietic stem cells and putative pre-leukaemic clones. Here, DNMT3A is linked to acute myeloid leukemia.